Fortifeye Vitamins Releases Next Gen, Zinc-Free Macular Defense

Fortifeye Vitamins Introduces Next Gen Zinc-Free Macular Defense

Through involvement in the clinical trial process, doctors at Mid Atlantic Retina played a key role in obtaining FDA approval for pegcetacoplan.

Time To Be Bold is a national public service awareness campaign helping the three million Americans 55 or older who are struggling with low vision regain their independence.

The next generation of dark adaptation testing features a wearable headset and an artificial intelligence-driven onboard technician.

Mrs. Silverberg will expand the company's strategic partnerships with key players in the eye care industry.

New report includes a definitive statement on best practices written by a team of 27 leading optometrists

Investment will accelerate domestic and international sales through expansion of workforce and company infrastructure

Twenty-five key opinion leaders map out strategies to make AMD education more practical for OD audiences

The ComfortPack™ is a dependable solution for anesthetizing the eye prior to intravitreal injections.

Clarion will add AdaptDx® to its portfolio of advanced ophthalmic technologies

New online learning community provides AdaptDx® users with product education and discussion forums

New Wearable Technology Helps People With Low Vision Regain Visual Independence

Funding by Early Stage Venture Capital Firm, Arab Angel and Strategic Partners

Macular Degeneration and treatments

Besides short sightedness and dry eyes, the most common eye diseases are macular degeneration, cataract and glaucoma. Do you know the difference between these 3 eye diseases?

Doing this will help save your sight and help you sleep better!

Dr. Randolph Kinkade, optometrist and founding member of the International Academy of Low Vision Specialists, announces the expanded version of Guide for Macular Degeneration Eyeglasses: Low Vision Treatment.

On Saturday, August 25, 2012, the Macular Degeneration Association (MDA) will host an educational symposium in Asheville, North Carolina at Doubletree by Hilton Asheville- Biltmore, 115 Hendersonville Road. The event is designed to give an overview o

Sonoma County's award-winning Petaluma acupuncturist, David Russell, L.Ac, announces new specialized acupuncture treatments for degenerative vision loss

Aciont is awarded a phase I SBIR $214K grant for the project titled "Novel Method for the Ocular Iontophoretic Delivery of Avastin® and Lucentis®"

Barbara Wirostko, Senior Medical Director, Team Lead Ophthalmology, Pfizer will give a presentation at GTCbio's 2nd Annual Ocular Disease Drug & Discovery Conference, May 27 - 28, 2010 in Boston, MA.